Prime Capital Investment Advisors, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1731446
OVERLAND PARK, KS
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,905,838
-$331,329 QoQ
Shares Held
15,085
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#853
of 2,266 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. GILD ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
63,152 | $75,746,409 | |
| 2 | ABBV |
AbbVie Inc.
|
128,509 | $32,338,004 | |
| 3 | JNJ |
Johnson & Johnson
|
127,237 | $32,314,380 | |
| 4 | AMGN |
Amgen Inc
|
15,849 | $5,739,239 | |
| 5 | MRK |
Merck & Co., Inc.
|
43,565 | $5,598,102 | |
| 6 | PFE |
Pfizer Inc
|
113,165 | $2,725,013 | |
| 7 | NVO |
Novo Nordisk A S
|
56,457 | $2,706,548 | |
| 8 | NVS |
Novartis AG
|
16,577 | $2,597,947 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,905,838 | 15,085 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,237,167 | 16,052 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,363,235 | 19,254 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,196,468 | 19,788 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,240,571 | 20,209 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,843,604 | 25,378 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,048,489 | 22,177 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,081,831 | 24,831 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,726,492 | 39,739 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,587,199 | 48,972 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,827,940 | 71,941 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,426,782 | 32,383 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,754,713 | 35,743 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,641,312 | 19,782 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,001,163 | 23,310 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $569,028 | 9,224 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $201,191 | 3,255 | Shares | Sole | 2022-08-12 | |
| 2021-03-31 | $60,041 | 929 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $79,641 | 1,367 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,292,514 | 52,105 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $4,891,383 | 63,574 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $87,992 | 1,177 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||